Luye Pharma Group (HK:2186) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Luye Pharma Group has issued an overseas regulatory announcement regarding the release of US$50 million 5.85% convertible bonds due in 2025. The company emphasizes that the information memorandum related to these bonds is not an invitation to the public to purchase or subscribe to securities. This move is aimed at ensuring equal information dissemination among investors in compliance with Hong Kong’s Listing Rules.
For further insights into HK:2186 stock, check out TipRanks’ Stock Analysis page.